###BASE_URL###

GENET-news articles on GE goats

go to page: 1 2 3 4 5 6

2008-09-05 |

Clones’ offspring may be in U.S. food supply: FDA

Food and milk from the offspring of cloned animals may have entered the U.S. food supply, the U.S. government said on Tuesday, but it would be impossible to know because there is no difference between cloned and conventional products. The U.S. Food and Drug Administration said in January meat and milk from cloned cattle, swine and goats and their offspring were as safe as products from traditional animals. Before then, farmers and ranchers had followed a voluntary moratorium on the sale of clones and their offspring.

2008-08-28 |

Bt cotton scare grips farmers, 120 goats perish in Orissa (India)

The scare of Bt cotton has come real and in a cruel way. Around 120 goats died after consuming Bt cotton leaves cultivated in Patnagarh sub-division on Sunday. Bt cotton is banned though its seeds are illegally available in the State. Police have detained one Shankar Deep who had taken on lease the land for cultivation of Bt cotton and have registered an FIR. [...] Villagers say that the goats died after chewing Bt cotton leaves. The goats were found fainting in the area where they ate Bt cotton leaves. On postmortem, it was found that all the goats had Bt cotton leaves in their stomach.

2008-08-18 |

Agresearch (New Zealand) seeks new long term GE pharma animal approvals

The Government’s biggest science company, Agresearch, has asked regulators to approve a wide-ranging application to genetically engineer 18 different animals for commercial production of pharmaceuticals. The pastoral science company would develop in the laboratory cell-lines including humans and monkeys, E coli and yeast. Using these they would develop GE cows, buffalo, sheep, pigs, goats, llamas, alpacas, deer, and horses.

2008-07-16 |

Nasdaq warns developer of GE pharma goats GTC of ’deficiency’

The Nasdaq notified GTC of ”the timetable for review of GTC’s continued inclusion on the Nasdaq Global Market” Tuesday. The Nasdaq said an aggregate market value of $50 million is required for GTC to continue listing on the global market. GTC has until July 31 to ”regain compliance” with the Nasdaq. If GTC’s stock reaches an aggregate market value of $50 million for 10 consecutive days at any point before July 31, the Nasdaq will determine at that time if the company in fact complies with the market’s listing standards.

2008-06-26 |

GTC Biotherapeutics signs up Ovation as U.S. partner in ”Pharming”

GTC Biotherapeutics is gearing up to take its first ”pharming” product, a drug harvested from genetically modified goats, to the U.S. market. The Framingham, MA-based company said today it signed an exclusive partnership with Ovation Pharmaceuticals to develop and market ATryn in the United States. Currently, ATryn is only sold in Europe. GTC stands to collect as much as $257 million in payments from Ovation if it can meet certain clinical, regulatory, and sales goals, with extra potential cash flow from royalties on product sales, according to the company’s statement.

2008-06-11 |

Old McDonald had a pharm - on GE pharma animals

Encompassed by pastoral green fields, the headquarters of GTC Biotherapeutics looks like any other New England farmstead. But its serenity is deceiving. Behind barn doors, the farm’s most valuable employees -- a herd of pygmy goats from New Zealand -- are working round the clock, their milk glands churning out hundreds of gallons of high-grade pharmaceutical compounds. The white gold extracted from the goats’ udders will someday command big bucks in the American healthcare marketplace -- or so GTC hopes. The company’s genetically modified animals possess a human gene that allows them to produce milk rich with a protein called antithrombin, which helps prevent blood clots from forming and staves off related conditions like heart attacks and strokes.

2008-04-24 |

Transgenic goats’ milk helps fend off E. coli-related illness in pigs

Pigs fed goats’ milk that was genetically modified to carry an important antibacterial enzyme found in human breast milk showed signs of better resisting attack by common E. coli bacteria than did pigs fed unmodified goats’ milk without the human enzyme, report researchers at the University of California, Davis. The findings, published in the May issue of the Journal of Nutrition, provide evidence that milk carrying high levels of the human lysozyme enzyme -- produced by genetically modified, or transgenic, goats -- may improve the gastrointestinal health of pigs and other animals that consume the milk. Pigs were used in this study because they have digestive systems that are similar to those of humans.

2008-04-10 |

No quick end for cloning product moratorium: USDA

The U.S. Agriculture Department said on Monday it will not lift a voluntary moratorium on selling meat and milk from cloned animals to consumers any time soon. In January, the U.S. Food and Drug Administration ruled that products from cloned cattle, swine and goats and their offspring were as safe as milk and meat from traditional animals. Before then, farmers and ranchers had followed a voluntary ban on the sale of cloned products.

2008-01-25 |

GTC Biotherapeutics (USA) warned on low stock price

Framingham-based GTC Biotherapeutics Inc. has been warned that if its stock doesn’t climb to $1, it could be delisted from the Nasdaq Global Market stock exchange. [...] GTC develops a protein treatment for blood clots in the milk of genetically modified goats. The company’s stock was trading at 80 cents a share this morning.

2008-01-16 |

U.S. FDA issues documents on the safety of food from animal clones

After years of detailed study and analysis, the Food and Drug Administration has concluded that meat and milk from clones of cattle, swine, and goats, and the offspring of clones from any species traditionally consumed as food, are as safe to eat as food from conventionally bred animals. There was insufficient information for the agency to reach a conclusion on the safety of food from clones of other animal species, such as sheep. FDA today issued three documents on animal cloning outlining the agency’s regulatory approach – a risk assessment; a risk management plan; and guidance for industry.

go to page: 1 2 3 4 5 6

Home: GENET